Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00440_DB00650_nanopub.RAIOakatEGhKOTcBfQaegVhj6Mg5dYh6WfSs17OtxpQJA#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00440_DB00650 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00440_DB00650 label "DDI between Trimethoprim and Leucovorin - The efficacy of Trimethoprim may be reduced by Leucovorin (folinic acid). The antibiotic, Trimethoprim, acts by blocking bacterial folic acid metabolism. Leucovorin may reduce the efficacy of Trimethoprim by providing an alternate source of folic acid. The therapeutic effect of Trimethoprim should be closely monitored. [drugbank_resource:DB00440_DB00650]" assertion.
- drugbank_resource:DB00440_DB00650 identifier "drugbank_resource:DB00440_DB00650" assertion.
- drugbank_resource:DB00440_DB00650 title "DDI between Trimethoprim and Leucovorin - The efficacy of Trimethoprim may be reduced by Leucovorin (folinic acid). The antibiotic, Trimethoprim, acts by blocking bacterial folic acid metabolism. Leucovorin may reduce the efficacy of Trimethoprim by providing an alternate source of folic acid. The therapeutic effect of Trimethoprim should be closely monitored." assertion.
- drugbank:DB00440 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00440_DB00650 assertion.
- drugbank:DB00650 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00440_DB00650 assertion.